Further investigations demonstrated that SIRT7 inhibits EMT in pancreatic cancer cells by transcriptionally repressing key target genes such as COL4A1 and SLUG, which are implicated in enhancing metastatic capabilities [133]. The gene discussed is SIRT7; the disease is familial pancreatic carcinoma.